Archives: Speakers

Cristi Stark serves in the role of Associate Director for the Office of Science (OS) within the Center for Tobacco Products (CTP), at the Food and Drug Administration (FDA). In this capacity, she focuses on application review management as well as leading high-priority cross-cutting regulatory and policy efforts. Cristi has over two decades of regulatory experience at FDA and has been with CTP since 2009. Within her time at CTP, Cristi has assisted with the establishment of TPSAC, served as the first TPSAC DFO, assisted with development and implementation of all premarket (PMTA, SE, EX REQ) and modified risk pathways, aided in establishment and reporting of performance metrics, served as a regulatory health project manager, Associate Director for Science Policy in OS, and more recently as the Director for the Division of Regulatory Project Management in OS. Prior to CTP she worked in two other FDA Centers, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Prior to FDA, she worked as a biologist for the National Cancer Institute. Cristi received her B.S. from the University of Maryland at College Park, and her M.S. from Johns Hopkins University.

Christer Hedström is Regional Sales Director Nordics at OutSystems, with more than 25 years of experience working closely with banks and financial institutions across the Nordics. Throughout his career, he has been driven by a genuine passion for helping clients navigate change and unlock new opportunities through technology.

Before joining OutSystems, Christer spent four and a half years as Country Manager at Anaplan, partnering with organizations such as EQT, NOBA Bank, and OP Bank. He also held the role of Director of Financial Services at Nets, where he worked with leading banks including Handelsbanken, SEB, Swedbank, Nordea, Resurs, and Skandiabanken. Earlier, at IBM, he was responsible for the Nordea account as Client Executive.

Today, Christer focuses on helping organizations move beyond simply running their business—empowering them to innovate, improve customer experiences, and drive meaningful transformation through automation and AI.

Rachael Pirrami went to school at the University of Toledo in Ohio where she got her B.S in Pharmaceutical Sciences, MBA, and PharmD. She worked as a Procurement and Logistics Pharmacy Intern at the Cleveland Clinic for 3 years and is now training as a Global Clinical Supply Chain Fellow at Takeda Pharmaceuticals. As a Fellow, she gets experience in all the various clinical supply chain areas including planning, operations, digital excellence, import and export, comparators and ancillaries, and vendor management.

Juliane’s work is all about connecting the dots between cutting-edge science and the everyday lives of those affected by rare conditions. She’s not just a researcher; she’s a champion for better health, working tirelessly to ensure that new, life-changing treatments move from the lab bench to the bedside as smoothly and swiftly as possible.

Juliane has worked in clinical research for more than 23 years, providing significant scientific and strategic design input as a subject matter expert for Phase I-IV rare disease trials and real-world studies. At Worldwide, Juliane provides operational strategies that are efficient and effective for delivering rare disease trials while being accessible to patients, caregivers, and families. Juliane is dedicated to improving patient outcomes and is passionate for advancing treatments and therapies for those afflicted by rare diseases.

Amy Raymond, PhD, PMP, is Executive Director and Therapeutic Strategy Lead with more than 25 years of experience in drug discovery and development. Her background includes progressive leadership roles in clinical operations and clinical strategy, with oncology clinical development experience spanning hematologic malignancies and solid tumors, rare to highly prevalent diseases, and all stages of the clinical development lifecycle.

In addition to her expertise in the unique dynamics of developing novel therapies for rare diseases, Dr. Raymond leads the Cell and Gene Therapy Hub at Worldwide Clinical Trials, leveraging a strong combination of scientific training and strategic leadership. Her development experience spans viral‑vectored gene therapies, TCR and CAR T-cell therapies for complex diseases, in vivo and ex vivo gene‑editing technologies, and a broad range of RNA‑based modalities. Her experiences confirm that understanding and aligning the needs of all stakeholders—patients and families, investigators and sites, regulators, and payers—is essential to delivering meaningful new therapies efficiently.

Dr. Raymond completed her doctoral training in molecular biology at University of California San Diego and post-doctoral training in molecular biology at Memorial Sloan-Kettering in New York City, New York, USA.

Susannah Streeter is a global financial commentator, Chief Investment Strategist at Wealth Club and an international keynote speaker and conference chair. She leads market and economic commentary at Wealth Club, helping investors build resilient portfolios, with a particular focus on long-term opportunities. As a former BBC Business Anchor, with 17 years on-air experience, Susannah has interviewed global CEOs, policymakers and world leaders, and has presented coverage from major international events. She also served as a Squadron Leader in the RAF Reserves, experience that continues to shape her approach to leadership and decision-making under pressure. Today, she works with organisations worldwide, delivering bespoke keynotes and chairing senior-level discussions that bring clarity, confidence, and perspective in uncertain times.